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term “non-Q infarction,” so common in today’s literature, repre-
sents sloppy thinking and sloppy science. Infarcts due to circumflex
disease may be very large and occasionally fatal and almost never
cause Q-waves. Significant anterior wall infarction often reduces
R-wave amplitude without resulting in Q-waves. The statement
that non–Q-wave infarcts are different from those with Q-waves is
using terminology that misrepresents the pathology. The view-
point article by Phibbs and colleagues (2), reviewing this issue in
detail three years ago in JACC, should be required reading. The
editorial staff can discourage the use of this term by insisting that
researchers who are ignorant of the pathology of infarction read
the article by Phibbs et al.
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REPLY
Dr. Ellestad assails our recent publication (1) on the angiographic
findings that characterize the “culprit lesion” in patients with acute
non–Q-wave myocardial infarction (MI) as representing “sloppy
thinking and sloppy science.” We presume this contentious alle-
gation is directed toward our use of the term “non–Q-wave MI,”
which, along with the comparator term “Q-wave MI,” is abhorred
by Dr. Ellestad and others (2) who contend that this binary
classification system “misrepresents the pathology” of MI and has
been termed variably as “a halfway house of the intellect” (3), as
having “no basis in scientific fact” (3), and as being “a meaningless
distinction” (2). Such pemicious rhetoric serves only to discredit
the stature and integrity of the physician assailants and to reinforce
the belief that such strong contrarian views are discordant with
mainstream cardiology opinion and practice.
At the time that the VANQWISH trial was conducted (1993 to
1996) and reported (1998) (4), the accepted terminology promul-
gated by both major national cardiology organizations (American
College of Cardiology and American Heart Association) consis-
tently endorsed the terms “Q-wave” and “non–Q-wave” MI in
their Consensus Management Guidelines (5), suggesting that
subject-matter experts and opinion leaders in cardiology did not
consider such concepts and terms meaningless or irrelevant.
More recently, of course, the older nomenclature of “Q-wave”
and “non–Q-wave” MI has been replaced by a new binary
classification system (“ST-segment elevation” and “non–ST-
segment elevation” MI), but because our current study was
undertaken in an era when the former classification was both
widely accepted and used, we decided for the sake of consistency to
use the term “non–Q-wave” MI rather than “non–ST-segment
elevation” MI in reference to our recent coronary angiographic
substudy (1).
We lament Dr. Ellestad’s uncritical assertion that both the
JACC editorial staff and the VANQWISH investigators are
“ignorant of the pathology of infarction.” We are all well aware of
the important distinction by which total or subtotal occlusion of
the circumflex or obtuse marginal branch coronary circulation can
“masquerade” as “non–Q-wave” MI; in fact, we were the first to
document (in 1987) the early electrographic findings of true
posterior MI (6), based on our careful and comprehensive assess-
ment of serial electrocardiograms (ECGs) in the Diltiazem Rein-
farction Trial (7). Moreover, we have contributed significantly to
the cardiology literature regarding the important electrocardio-
graphic features of non–Q-wave (non–ST-segment elevation) MI,
(8–10) and obviously incorporated these same rigorous criteria for
use in the VANQWISH study (4), which, we believe, permitted us
to accurately and reliably exclude posterior MI from our study
population.
Although our views are unlikely to dissuade Dr. Ellestad and
the vocal minority of cardiologists who tenaciously adhere to the
holistic notion that “an infarct is an infarct” electrocardiographi-
cally, pathogenetically, clinically, angiographically, and prognosti-
cally—a view, unfortunately, that ignores and disdains an abun-
dance of scientific information that has been acquired and
assimilated over more than 25 years of careful study—we hope that
our recent report on the angiographic characteristics of “culprit
lesions” will aid more cognitive cardiologists to focus on ways of
optimizing the care and management of their patients with
non–Q-wave/non–ST-segment elevation MI rather than getting
“lost among the forest and trees” of a largely outmoded terminol-
ogy battle that is of little relevance to contemporary clinical
practice.
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